Introduction
About 20-30% of the patients with epilepsy continue to have seizures despite adequate antiepileptic therapy [1] . In a part of these patients a neurosurgical operation can lead to a real improvement. The objective of the presurgical evaluation is the correct localization of the epileptogenic focus (= region of brain responsible for generating epileptic seizures) [2] . For this reason, it is mandatory that the exact localization of the epileptogenic focus be determined preoperatively. The EEG monitoring is still the "gold standard" for the localization of the epileptogenic focus. However, in 20-50% it is difficult or impossible to localize the epileptogenic focus in the surface EEG. In these cases semi-invasive or invasive EEG monitoring is necessary [3] [4] [5] . Non-invasive functional and morphological methods have been developed for the precise localization of the epileptogenic focus in order to increase the safety and possibly the avoidance or at least the optimization of the invasive localization methods. PET studies with 11 C-Flumazenil have shown the involvement of the benzodiazepine receptors (BDR) in epilepsy [6] [7] [8] . The aim of this study was to examine the clinical value of 123 Iodine-
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Iomazenil (a derivate of Flumazenil) SPECT in relation to interictal rCBF SPECT, EEG and MRI findings in patients with therapy-resistant mesial temporal lobe epilepsy. and comparison to those of healthy volunteers (n = 9), both for the benzodiazepine receptor SPECT and the interictal rCBF study. A variation of >2 standard deviations was considered significant. After spatial standardization and normalization of the image data, 123 I-Iomazenil SPECT was analyzed pixelby-pixel in the subgroups, with right and left predominant deficiency according to asymmetry indices. Direct comparisons were performed with the normal group. The calculated t-maps were merged with the brain anatomy as shown by highresolution MRI using a dedicated Computerized Brain Atlas (CBA) system. All patients underwent a surgical procedure (7/9 an amygdalohippocampectomy and 2/9 an anterior temporal lobectomy) and all patients had been seizure free for at least 12 months postoperative. We considered that the resected cerebral region correspond correctly with the epileptogenic focus, when the patients had been postoperatively seizure free for at least 12 months.
Patients and methods

Results
Ictal focal EEG activity over the mesial temporal region was obtained in all patients during intensive monitoring. High-resolution MRI revealed a focal anomaly in 8 patients. In all but one patient the 123 I-Iomazenil SPECT study showed reduced
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Discussion
In the literature the average sensitivity for the interictal CBF SPECT is 44% (range 0-72%), for the ictal CBF SPECT 96% (range 67-100%), for FDG-PET 74%, Flumazenil PET 97%, CBF PET 47% and 123 I-Iomazenil SPECT 85% [7, 8, 10, 11] . Our results for the interictal CBF SPECT with 25% lie in the lower range of the published results. The 123 I-Iomazenil SPECT with a sensitivity of 89% lies in the upper range of the published data. The results confirm the assumption that the reduction of the GABA-transmitted inhibition plays a key role in the spread of the seizure potential, and that the inhibitory transmission is disturbed in the epileptogenic focus [9, 11, 12] . 123 I-Iomazenil shows a specific binding on the central benzodiazepine receptors at the neuronal membrane and reduced benzodiazepine receptor binding have been described in human epileptogenic foci [7, 8, [10] [11] [12] , and, thus, possibly allows a more specific detection of the epileptogenic focus as the demonstration of the glucose metabolism or the cerebral blood flow. In the literature, there are various hypotheses as to the cause of the focal reduction of the benzodiazepine binding. Of the various theses, it could be that a loss of neurons is responsible, that there is a degeneration of the GABAergic neurons, a loss of the inhibitory synapses, down regulation of the benzodiazepine receptors or an irreversible binding of endogenous ligands on the benzodiazepine receptors [13] [14] [15] [16] .
Conclusion
The study of the benzodiazepine receptors density by 123 I-Iomazenil brain SPECT gives valid information in candidates for epilepsy surgery and allows reliable localization of epileptogenic foci. In comparison to interictal rCBF SPECT, its sensitivity and positive predictive values are considerably higher and are comparable to ictal rCBF SPECT. 123 I-Iomazenil SPECT is logistically simpler and finally less expensive than ictal ECD SPECT and gives complementary information to rCBF and metabolic data as derived from FDG PET. The sensitivity of benzodiazepine receptors SPECT using 123 I-Iomazenil is comparable with PET studies using 11 C-Flumazenil. A reliable spatial localization of the functional data is possible by displaying structures adapted to the individual anatomy on seizure localization and seizure propagation. 123 I-Iomazenil SPECT should have a firm place in the preoperative diagnostic routine, particularly with equivocal EEG or MRI findings.
